Endoscopic Considerations in Gastroesophageal Reflux Disease
Gastroesophageal reflux disease affects approximately 50 million Americans and some studies estimate the prevalence approaches 20 % of the population in many Western countries. Approximately 50 % of the U.S. population experiences gastroesophageal reflux disease astroesophageal reflux disease-related symptoms once a month, and one in ten Americans experience symptoms of heartburn and bloating every day. This tremendously prevalent condition has had and will continue to have a significant economic impact on the Unites States and other developed Western countries. In view of that, numerous countries expend a considerable amount of resources on direct and indirect costs attributable to the prevention and treatment of reflux disease. Gastroesophageal reflux disease has a substantial impact on clinical and financial welfare since patients suffering from this disorder generally report a diminished health-related quality of life (HRQL), reduced work productivity, and depressed psychological health.
KeywordsBurning Obesity Catheter Adenocarcinoma Mold
- 9.Fockens P, Bruno MJ, Gabbrielli A, Odegaard S, Hatlebakk J, Allescher HD, et al. Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the gatekeeper reflux repair system. Endoscopy. 2004;36(8):682–9.PubMedCrossRefGoogle Scholar
- 25.Wendling MR MW, Perry K. Impact of transoral incisionless fundoplication on subjective and objective GERD indices: a meta-analysis of the published literature. J Soc Am Gastrointest Endosc Surg (Unpublished data).Google Scholar